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ABSTRACT
A case of localized tracheobronchial primary amyloidosis masquerading as “bronchial asthma”
is presented. Computed tomography of the chest and fiberoptic bronchoscopy image are
included. Tracheobronchial primary amyloidosis is a rare, but potentially curable cause of
airway obstruction mimicking asthma.
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INTRODUCTION
Primary amyloidosis involving the
tracheobronchial tree is extremely uncommon. It
produces tumour-like lesions in the tracheo-
bronchial tree. The clinical presentation includes
symptoms such as dysponea, cough, haemop-
tysis, stridor and wheezing. We present a case
report of localized tracheobronchial primary
amyloidosis masquerading as “bronchial
asthma”.
CASE REPORT
A 50-year-old nonsmoker male was
symptomatic with episodic cough and
wheezing for the last five years. He was being
treated as a case of “bronchial asthma” in
another hospital with partial response to oral
and inhaled bronchodilators. He was also
complaining of intermittent streaky
haemoptysis for the same duration. The patient
reported to our hospital for the treatment of
acute exacerbation of his symptoms. On
examination, he was in respiratory distress.
Stridor was audible over the trachea and
rhonchi were auscultated bilaterally.
Examination of other systems was not
remarkable. Investigations revealed hemoglobin
13 g/dl with a total leukocyte count of 15×109/
L (82% neutrophils, 18% lymphocytes). The ESR
was raised at 51 mm/hour (Westergren’s
method). All biochemical investigations were
within normal limits. The chest radiograph was
normal1. Computed tomography of the chest
showed circumferential thickening of the
tracheobronchial tree [Figures 1(a), 1(b)].
Pulmonary function test revealed the following
(as % predicted) FVC 52%, FEV1 37%, FEV1/
FVC 73%, PEFR 33%, FEF25-75 17%, FEF50 14%
and FEF75 11%. However, there was no
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reversibility of the airway dysfunction. Arterial
blood gases, while breathing room air, were
PaO2 7.49 kPa (normal range 11.3-12.6 kPa),
PaCO2 4.81 kPa (normal range 4.7-6.0 kPa).
pathology of the biopsy specimen  from these
projectios confirmed the presence of
amyloidosis. There were no Bence Jones
proteins in urine. Serum protein electrophoresis
result was normal. Electrocardiogram and
echocardiogram were normal. A rectal biopsy
specimen did not show any evidence of rectal
amyloidosis. The patient was treated with
amoxycillin-clavulanate combination, intra-
venous corticosteroids, oral and inhalational
bronchodilators. Thereafter, bronchoscopic
piecemeal excision of nodular amyloidosis was
performed. A few weeks later, the patient was
also subjected to neodymium:yttrium-
aluminium-garnet (Nd YAG) laser treatment. A
repeat bronchoscopy examination did not show
much improvement. Subsequently, he was
started on melphalan (0.25 mg/kg/day) and
prednisolone (2 mg/kg/day) for four days
every month. In addition, colchicine 0.5 mg
twice a day orally was also administered. He
was reviewed at three months. There was an
excellent clinical response. There were no stridor
or rhonchi and he did not require any broncho-
dilator therapy. A repeat pulmonary function
test revealed the following (as % predicted):
FVC 95%, FEV1 97%, FEV1/FVC 83%, PEFR
80%, FEF25-75 98%, FEF50 74% and FEF75 118%. On
bronchoscopy examination, there was a
Figure 1(a). Contrast enhanced CT scan at the level
of aortic arch showing diffuse circumferential
thickening of the tracheobronchial airway just
above the carina.
Figure 1(b). Contrast enhanced CT scan just below
the carina showing diffuse circumferential wall
thickening in both right and left main bronchi.
In view of the computed tomography
findings, he was subjected to a fibreoptic bron-
choscopy examination. It revealed yellowish,
flat submucosal lesions starting at the level of
the vocal cords. In addition, there were friable
and glistening yellowish polypoid projections
from the walls of the trachea (Figure 2). The
carina was also covered with these projections.
The rest of the bronchial tree could not be
evaluated due to marked narrowing of both
main bronchi by these  projections. Histo-
Figure 2. Fiberoptic bronchoscopy view shows
glistening yellow polypoid projections from the
tracheal wall.
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significant degree of regression of lesions.
Follow-up bronchoscopy after six months
revealed almost normal tracheobronchial tree.
DISCUSSION
Amyloidosis is characterized by insoluble
protein fibrils with characteristic physico-
chemical properties. Amyloidosis may be
primary or secondary to other diseases.
Localized amyloidosis has not been chemically
identified but is usually defined by the absence
of systemic features.
Primary amyloidosis involving the tracheo-
bronchial tree is rare. It produces tumour-like
lesions in the tracheobronchial tree. The patients
present with a variety of symptoms such as
dyspnoea, cough haemoptysis, stridor, rhonchi
and crepitations. These nodular lesions produce
progressive airway obstruction resulting in
symptoms suggestive of bronchial asthma,
atelectasis and obstructive pneumonitis.
Management includes endoscopic excision of
amyloid deposits, thoracotomy and even
radiotherapy2. Spontaneous regression of
diffuse tracheobronchial amyloidosis has also
been described3. Fatal haemorrhage can occur
following endoscopic piecemeal excision of
amyloid nodules4. Bronchoscopic laser excision
is considered to be a better option of treatment
as amyloid is very sensitive to laser photo-
irradiation. Repeated sessions are required and
recurrence is rare.  Carbon dioxide laser may
have an advantage over the neodymium YAG
laser in the management of localized
tracheobronchial amyloidosis because of lesser
bleeding5. Successful  treatment of primary
amyloidosis with intermittent chemotherapy
consisting of melphalan and prednisolone has
also been reported6. However, this mode of
treatment has not been tried earlier in localized
tracheobronchial amyloidosis. Recently,
Aggarwal et al7 have described two patients
with tracheobronchial amyloidosis. Both these
patients were reported to be doing well without
any definitive treatment.
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